Related Experiment Video
Updated: Jun 17, 2025

Forskolin-induced Swelling in Intestinal Organoids: An In Vitro Assay for Assessing Drug Response in Cystic Fibrosis Patients
Published on: February 11, 2017
Improving growth in infants with CF
Megan E Gabel1,2, Rachel E Gaudio3, Ala K Shaikhkhalil4,5
1University of Rochester Medical Center, University of Rochester, Rochester, New York, USA.
Insights
Cystic fibrosis (CF) infants face growth challenges from birth, impacting health outcomes. Early nutritional support and interdisciplinary care are crucial for improving growth and survival in children with CF.
Area of Science:
- Pediatric Nutrition
- Gastroenterology
- Pulmonology
Background:
- Cystic fibrosis (CF) is a genetic disorder causing chronic pulmonary and gastrointestinal issues.
- Malnutrition and poor growth are significant complications of CF, correlating with adverse clinical outcomes.
- Early diagnosis via newborn screening enables prompt nutritional intervention and clinical management.
Purpose of the Study:
- To highlight the critical importance of optimizing growth in infants diagnosed with cystic fibrosis.
- To underscore the challenges and priorities in managing infant growth in CF care.
- To emphasize the need for a comprehensive, interdisciplinary approach to CF infant management.
Main Methods:
- Review of current understanding of growth obstacles in infants with CF.
- Emphasis on the role of early nutritional counseling and clinical follow-up.
- Highlighting the necessity of integrated care involving registered dietitians and social work.
Main Results:
- Infants with CF often experience intrauterine growth restriction and lower birth weights.
- Improved infant growth in CF is demonstrably linked to better clinical outcomes and survival rates.
- Despite advances, challenges in linear growth, nutrition biomarkers, and health inequities persist.
Conclusions:
- Optimizing growth is a paramount concern for infants with cystic fibrosis.
- An interdisciplinary team approach is essential for addressing the complex nutritional and health needs of CF infants.
- Overcoming barriers like social determinants of health is vital for global CF communities.
Abstract:
Cystic fibrosis (CF) results in chronic pulmonary infections, inflammation, pancreatic insufficiency, and multiple gastrointestinal manifestations. Malnutrition and poor growth are hallmarks of CF, and strongly associated with poor outcomes. Through newborn screening, many infants can be diagnosed within a few days of life, which allows for early initiation of nutritional counseling and close clinical follow-up. Obstacles to growth for infants with CF start in utero, as newborns with CF can have a lower birth weight than the general population. Improving infant growth has been linked to improved clinical outcomes and survival. It remains a top priority and challenge for caregivers and healthcare teams. An interdisciplinary approach, including registered dietitian and social work support, is essential to optimize health for infants with CF. Remaining barriers to normalcy include deficits in linear growth, lack of accurate nutrition biomarkers, persistence of inequities related to social determinant of health, particularly in the global CF community.
More Related Videos
Related Concept Videos
Cystic Fibrosis: Management
Sinus disease and chronic...
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
Acute Respiratory Failure-V
Ensure that patients are monitored continuously for their response to therapy, including changes in...

